Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Overexpression of COX-2 causes early hair loss in mice, but can be prevented with a COX-2 inhibitor.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Nanozymes could improve cancer diagnosis and treatment by mimicking enzymes and enhancing delivery to tumors.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Baldness may lower the risk of testicular cancer.

Understanding how certain proteins and genetic changes control skin stem cells is key to treating skin diseases.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Finasteride is effective for hair loss but has controversial side effects.

Hereditary factors affect acne duration, not severity, and late-onset acne in females has different causes.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Chemical hair straightening can damage hair and health, needing safer alternatives and stricter regulations.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Stress keratins are expressed less in diseased skin and are linked to differentiation, inflammation, and immunity.

Controlling cellular changes can enable safe rejuvenation without cancer risk.

Dermatologists found teledermatology useful and confidence-boosting for diagnosing skin conditions, but faced limitations like technical issues and prescription restrictions. Despite this, they saw its potential to improve access to skin care, especially in remote areas.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Cell polarity signaling controls tissue mechanics and cell fate, with complex interactions and varying pathways across species.